Top Stories

Internists most likely to switch patients off Avandia

July 17, 2007

Though the FDA has yet to advise on the cardiovascular safety of GlaxoSmithKlines Avandia type 2 diabetes drug, some physicians are taking matters into their own hands.
 

J&J, Novartis second quarter sales rise

July 17, 2007

Johnson Johnson reported a 13% rise in sales overall to $15.1 billion from $13.4 billion.
 

Industry's finest gather for MM&M Awards judgment day

July 17, 2007

We are a step closer to knowing the finalists of the MM&M Awards 2007 this morning after 48 of the industry's finest leaders and thinkers spent an entire day yesterday reviewing and scoring the 700-plus submissions.
 

In Other News

Pharma marketers embrace online media: survey

July 13, 2007

Pharma companies are increasingly relying on the Internet and alternative media to promote products to doctors and patients, results of a new survey show.
 

House OKs PDUFA bill, sans DTC restrictions

July 12, 2007

The House has approved legislation that would reauthorize PDUFA and strengthen the FDAs hand, allowing it to require post-market drug safety studies and fine companies as much as $250,000 for airing false and misleading ads.
 

FDA panel to review Merck HIV treatment

July 12, 2007

The FDA is scheduled to convene a panel of outside experts to review Mercks developmental HIV treatment Isentress on Sept. 5.
 

Merck and Ariad in billion-dollar cancer drug pact

July 12, 2007

Merck and Ariad Pharmaceuticals have agreed to the terms of a potential billion-dollar global collaboration deal to develop and market Ariads cancer treatment known as AP23573.
 

Sponsored Links

Extend Your Reach with About.com Health

About.com Health delivers a robust audience of 7 million uniques each month who come for relevant health information in more than 80 in-depth topic areas. About.com Health delivers a high quality audience: a high concentration of women between the ages of 25-54 - higher than other health web sites - and an audience that goes online more frequently for health information. To reach this healthy audience, contact Michael Frick at mfrick@about.com or find out more at humanexperience.about.com.

In Other News

J&J still seeking approval of sexual dysfunction pill

July 11, 2007

Johnson Johnson hasnt given up on becoming first to market with an Rx drug approved for premature ejaculation, The Wall Street Journal reports.
 

Product news

July 17, 2007

Stiefel Laboratories announced that the FDA has approved its new drug application for Extina (ketoconazole) foam, 2% for the treatment of seborrheic dermatitis.
 

People news

July 17, 2007

Keryx Biopharmaceuticals announced that William Kane has joined the company as VP, commercial operations.
 

Account wins

July 17, 2007

Johnson Johnson has split its $3 billion media buying account among Interpublic Group, Omnicom Group, and Aegis Group, with some pieces being handled by independent shop Naked Communications and WPP Groups JWT, following a four-month review.
 

Company news

July 17, 2007

AstraZeneca and IBM announced that they have signed a global strategic outsourcing agreement worth $1.7 billion over seven years.
 



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.